200 related articles for article (PubMed ID: 14502828)
1. [On new mechanisms of action of centrally active drugs].
Castrén E; Panula P
Duodecim; 2003; 119(15):1487-95. PubMed ID: 14502828
[No Abstract] [Full Text] [Related]
2. Epigenetic marking and neuronal plasticity.
Duman RS; Newton SS
Biol Psychiatry; 2007 Jul; 62(1):1-3. PubMed ID: 17572174
[No Abstract] [Full Text] [Related]
3. [Interaction between neurological and psychological control mechanisms].
Robberstad M
Tidsskr Nor Laegeforen; 1983 Feb; 103(4):295-7. PubMed ID: 6857611
[No Abstract] [Full Text] [Related]
4. Emerging role of the FGF system in psychiatric disorders.
Riva MA; Molteni R; Bedogni F; Racagni G; Fumagalli F
Trends Pharmacol Sci; 2005 May; 26(5):228-31. PubMed ID: 15860368
[TBL] [Abstract][Full Text] [Related]
5. Deconstructing psychiatric disorders, part 2: An emerging, neurobiologically based therapeutic strategy for the modern psychopharmacologist.
Stahl SM
J Clin Psychiatry; 2003 Oct; 64(10):1145-6. PubMed ID: 14658960
[No Abstract] [Full Text] [Related]
6. Neurobiology of psychotropic drugs: modes of action and therapeutic efficacy.
Schmidt LG
Pharmacopsychiatry; 1994 Jul; 27 Suppl 1():2-3. PubMed ID: 7984693
[No Abstract] [Full Text] [Related]
7. [Prescription and monitoring of psychotropic drugs].
Haffen E; Thibaut F
Rev Prat; 2009 Feb; 59(2):267-77. PubMed ID: 19317150
[No Abstract] [Full Text] [Related]
8. Outside the box.
Newnes C
Ment Health Today; 2006 Nov; ():21. PubMed ID: 17133682
[No Abstract] [Full Text] [Related]
9. Influence of common drugs and related factors on stroke outcome.
Goldstein LB
Curr Opin Neurol; 1997 Feb; 10(1):52-7. PubMed ID: 9099528
[TBL] [Abstract][Full Text] [Related]
10. A protocol for the evaluation of new psychoactive drugs in man.
Shulgin AT; Shulgin LA; Jacob P
Methods Find Exp Clin Pharmacol; 1986 May; 8(5):313-20. PubMed ID: 3724306
[TBL] [Abstract][Full Text] [Related]
11. [Epigenetics in the therapy of psychiatric disorders].
Iannitelli A; Biondi M
Riv Psichiatr; 2014; 49(1):1. PubMed ID: 24572577
[No Abstract] [Full Text] [Related]
12. Special issue on CNS experimental medicine.
Dawson GR; Dourish CT; Goodwin GM
J Psychopharmacol; 2011 Sep; 25(9):1145-7. PubMed ID: 21994313
[No Abstract] [Full Text] [Related]
13. Experimental and clinical vectors in pharmacology.
Masserman JH
Curr Psychiatr Ther; 1976; 16():107-16. PubMed ID: 991623
[No Abstract] [Full Text] [Related]
14. Choosing drug of choice from restrictive formulary.
Bender KJ
J Clin Psychopharmacol; 1997 Jun; 17(3):145-8. PubMed ID: 9169956
[No Abstract] [Full Text] [Related]
15. Centrally acting drugs.
Bateman DN; Chaplin S
Br Med J (Clin Res Ed); 1988 Feb; 296(6619):417-9. PubMed ID: 3125927
[No Abstract] [Full Text] [Related]
16. Clinical pharmacology in psychiatry. Selectivity in Psychotropic drug action--promises or problems? Fourth International Meeting on Clinical Pharmacology in Psychiatry. Bethesda, Maryland, 5-8 September 1985. Proceedings.
Psychopharmacol Ser; 1987; 3():1-290. PubMed ID: 3823087
[No Abstract] [Full Text] [Related]
17. [Off-label use of drugs in psychiatry and neurology].
Wallesch CW
Fortschr Neurol Psychiatr; 2004 May; 72(5):243-4. PubMed ID: 15136944
[No Abstract] [Full Text] [Related]
18. Abstracts of the 2nd European College of Neuropsychopharmacology workshop. Nice, France, March 15-18, 2001.
Eur Neuropsychopharmacol; 2001 Mar; 11 Suppl 1():S1-S23. PubMed ID: 11239750
[No Abstract] [Full Text] [Related]
19. [Genericum? Which one should I choose?].
Kovács G
Neuropsychopharmacol Hung; 2013 Mar; 15(1):2. PubMed ID: 23542753
[No Abstract] [Full Text] [Related]
20. [Neurotransporters : new aspects of the mechanism of action of psychotropic drugs].
Lesch KP; Beckmann H
Nervenarzt; 1993 Jan; 64(1):75-9. PubMed ID: 8094894
[No Abstract] [Full Text] [Related]
[Next] [New Search]
